Losartan Potassium Tablets Recalled for AZIDO Impurity Above Limits
Preferred Pharmaceuticals is recalling Losartan Potassium 50mg tablets due to AZIDO impurity levels exceeding acceptable limits. The affected product was distributed to California, Indiana, and Florida.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II pharmaceutical recall for CGMP deviation with AZIDO impurity levels exceeding acceptable limits. No illnesses or injuries have been reported, making this a potential risk-of-harm product without yet-documented harm, consistent with the High severity threshold.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling certain batches of Losartan Potassium Tablet USP 50mg due to a current good manufacturing practice (CGMP) deviation involving elevated AZIDO impurity levels. The affected product was distributed nationwide to California, Indiana, and Florida.
The recalled lots are E1321O, E2521H, and E2621F, all expiring May 31, 2023. The total quantity includes 44 bottles containing 90 tablets each and 33 bottles containing 30 tablets each.
Patients taking Losartan Potassium from the affected lots should consult their healthcare provider or pharmacist to determine if their medication is included in this recall. Do not stop taking the medication without medical guidance.
The recalled product
- Product
- Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Antihypertensive
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: E1321O
- Exp.: 5/31/2023 Lot: E2521H
- Exp.: 5/31/2023 Lot: E2621F
- Exp.: 5/31/2023
Distribution
Related recalls
Same manufacturer · Preferred Pharmaceuticals, Inc.
See all →- ModeratePreferred Pharmaceuticals Recalls Lidocaine Ointment Due to Content Uniformity Failures
FDA (Drugs) · 2026-10-14
- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- ModerateOndansetron blister packs recalled because tablets are falling out
FDA (Drugs) · 2025-12-24
- ModerateClindamycin Hydrochloride Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-07
- HighIbuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-09-04
Same hazard · azido impurity
See all →- HighLosartan Potassium Tablets Recalled for Elevated AZIDO Impurity Levels
FDA (Drugs) · 2022-07-06
- HighFDA Recalls Losartan-Hydrochlorothiazide Tablets for Manufacturing Quality Deviations
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for Manufacturing Impurity Issues
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium tablets recalled for elevated AZIDO impurity
FDA (Drugs) · 2022-07-06
- HighLosartan Potassium Tablets Recalled for CGMP Deviations and Elevated Impurity
FDA (Drugs) · 2022-06-08
Similar recalls
- HighLosartan Potassium tablets recalled for manufacturing impurity above limits
FDA (Drugs) · 2022-05-11
- HighLosartan Potassium Tablets Recalled Due to Unacceptable Chemical Impurity Levels
FDA (Drugs) · 2022-05-11
- HighLosartan Potassium tablets recalled for AZIDO impurity above limits
FDA (Drugs) · 2022-05-11
- HighLosartan Potassium 50 mg tablets recalled due to azido impurity
FDA (Drugs) · 2022-05-04
- SeverePreferred Pharmaceuticals Recalls Losartan Potassium Tablets Due to Impurity
FDA (Drugs) · 2019-05-22
- HighLosartan Potassium and HCTZ Tablets Recalled for AZIDO Impurity Deviations
FDA (Drugs) · 2022-06-01